Publication:
Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort

dc.contributor.authorsGazel, U.; Colak, S.; Sari, A.; Cansu, D. U.; Yazici, A.; Cefle, A.; Bes, C.; Karadag, O.; Omma, A.; Direskeneli, H.; Alibaz-Oner, F.
dc.date.accessioned2022-03-12T22:54:51Z
dc.date.accessioned2026-01-11T08:05:40Z
dc.date.available2022-03-12T22:54:51Z
dc.date.issued2020
dc.description.abstractObjective. Immunoglobulin (Ig) A vas-culitis affects children more commonly than adults and previous literature lacks any formal damage assessment. Our aim in this study is to investigate the disease course, relapse rates and prog-nostic factors in adult patients with IgA vasculitis and to evaluate the disease-related damage. Methods. We assembled a retrospective cohort of adult IgA vasculitis from six tertiary Rheumatology Centres in Turkey. The demographics, clinical characteris-tics, treatment and outcomes of patients were abstracted from medical records. Results. The study included 130 (male/female: 85/45) patients and the mean age was 42.2 +/- 17 years. Cutaneous manifestations and arthritis/arthralgia were the most common clinical mani-festations. One hundred thirteen pa-tients (86.9%) were treated with oral glucocorticoids (GC). As additional immunosuppressive (IS) agents, aza-thioprine was given to 44 (34.9%) and pulse cyclophosphamide to 18 (12.6%) patients. Seventy-nine patients (60%) had follow-up of median 15 (IQR 7-40) months. Twelve (15%) patients re-lapsed during follow-up. The mean VDI score was 0.4 in the last visit. Nineteen (24.7%) patients had at least one dam-age item at the end of follow-up. Most frequent damage items were renal 11 (42%), ocular 4 (15%) and cardiovas-cular 4 (15%). Conclusion. In this cohort the most fre-quent damage item was renal and was related to the disease itself. Damage score was higher in patients with more severe disease and treated more aggres-sively. Our results suggest that more ef-fective treatment options are needed in a subgroup of patients with IgA vasculitis to prevent the damage related with the vasculitis, especially with more severe disease.
dc.identifier.doidoiWOS:000571551900023
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.urihttps://hdl.handle.net/11424/236553
dc.identifier.wosWOS:000571551900023
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGY
dc.relation.ispartofCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectimmunoglobulin A vasculitis
dc.subjectHenoch Schonlein purpura
dc.subjectdamage
dc.subjectprognosis
dc.subjectleukocytoclastic vasculitis
dc.subjectHENOCH-SCHONLEIN PURPURA
dc.subjectPREDICTIVE FACTORS
dc.subjectCLINICAL SPECTRUM
dc.subjectGENE POLYMORPHISM
dc.subjectRENAL INVOLVEMENT
dc.subjectCHILDREN
dc.subjectNEPHRITIS
dc.subjectDISEASE
dc.subjectMANIFESTATIONS
dc.subjectPROGNOSIS
dc.titleDamage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageS160
oaire.citation.issue2
oaire.citation.startPageS155
oaire.citation.titleCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
oaire.citation.volume38

Files